1
|
Baleriola C, Tu E, Johal H, Gillis J, Ison MG, Law M, Coghlan P, Rawlinson WD. Organ donor screening using parallel nucleic acid testing allows assessment of transmission risk and assay results in real time. Transpl Infect Dis 2012; 14:278-87. [PMID: 22519518 DOI: 10.1111/j.1399-3062.2012.00734.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2011] [Revised: 10/23/2011] [Accepted: 12/21/2011] [Indexed: 11/26/2022]
Abstract
Expansion of the donor pool may lead to utilization of donors with risk factors for viral infections. Donor laboratory screening relies on serological and nucleic acid testing (NAT). The increased sensitivity of NAT in low prevalence populations may result in false-positive results (FPR) and may cause unnecessary discard of organs.We developed a screening algorithm to deal, in real time, with potential FPR. Three NAT assays: COBAS AmpliScreen assay (CAS), AmpliPrep Total Nucleic Acid Isolation/CAS, and AmpliPrep/TaqMan assays, were validated and used in parallel for prospective screening of increased-risk donors (IRD), and the probability of FPR was calculated. The lower limit of detection of this algorithm was 9.79, 21.02, and 4.31 IU/mL for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus, respectively, with an average turn-around-time of 7.67 h from sample receipt to result reporting. The probability that a donor is potentially infectious with two NAT concordant results was >90%. NAT screening of 35 IRD within 18 months resulted in transplantation of 102 additional organs that without screening would either not be used or used with restrictions in Australia. Using a parallel testing algorithm, real-time confirmation of seropositive donors allows use of organs from IRD and safer expansion of the donor pool.
Collapse
Affiliation(s)
- C Baleriola
- Virology, Department of Microbiology, South Eastern Area Laboratory Services (SEALS), Prince of Wales Hospital, Sydney, New South Wales, Australia
| | | | | | | | | | | | | | | |
Collapse
|
2
|
Sárváry E, Gerlei Z, Dinya E, Tóth E, Varga M, Chmel R, Molnar M, Remport A, Nemes B, Kobori L, Görög D, Fazakas J, Gaal I, Járay J, Perner F, Langer R. Hepatitis C infected hemodialysis and renal transplant patients with elevated α-glutathione S-transferase have increased risk for liver damage. Interv Med Appl Sci 2010. [DOI: 10.1556/imas.2.2010.2.5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
AbstractPatients on hemodialysis (HD) and renal transplant recipients (RT) have a high prevalence of HCV infection. Theaimof our study was to determine the prevalence of HCV-RNA in the anti-HCV positive patients and to compare the biochemical parameters of PCR(+) and PCR(−) subgroups.Methods:The 525 sera were screened for anti-HCV. HCV-RNA was detected by polymerase chain reaction (PCR) and liver enzymes [SGOT, SGPT, GGT,α-glutathione S-transferase (GST)] were measured.Results:Active viraemia was found only in 187 of 289 (65%) seropositive HD patients in contrast to 53 of 53 (100%) of seropositive RT patients. Significantly increased (p<0.05) GST values (9.9 μg/l) were found in the PCR(+) subgroups compared to GST levels (2.7 μg/l) of the PCR(−) subgroups. Elevated GST concentration was found in 80% (208/251) of PCR(+) patients. The measured enzymes were not elevated in HCV infected patients. Six percent of HD and 11% of RT patients were screened before seroconversion. Diagnostic sensitivity (80%) and specificity (79%) of GST were calculated as good for early liver damage caused by HCV. In contrast, the sensitivity of the measurement of other liver enzymes were very weak (SGOT: 8%; SGPT: 10%; GGT: 42%).Conclusion:The significantly higher viraemia of the RT subgroup could be related to the immunosuppressive therapy. Increased GST level may be a useful indicator of tissue damage during HCV infection. If HCV infection is suspected, PCR and GST measurement should be performed, even if anti-HCV result is negative.
Collapse
Affiliation(s)
- Enikő Sárváry
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
- 4 Transplantation and Surgical Clinic, Semmelweis University, Baross u. 23–25, H-1082, Budapest, Hungary
| | - Zs. Gerlei
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - E. Dinya
- 2 EGIS Pharmacenticals LTD., Budapest, Hungary
| | - E. Tóth
- 3 EUROCARE Dialysis Center, Békéscsaba, Hungary
| | - M. Varga
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - R. Chmel
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - M. Molnar
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - A. Remport
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - B. Nemes
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - L. Kobori
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - D. Görög
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - J. Fazakas
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - I. Gaal
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - J. Járay
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - F. Perner
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - R. Langer
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| |
Collapse
|
3
|
Peng M, Dai CB, Chen YD. Expression and immunoreactivity of an epitope of HCV in a foreign epitope presenting system. World J Gastroenterol 2005; 11:3363-7. [PMID: 15948240 PMCID: PMC4315989 DOI: 10.3748/wjg.v11.i22.3363] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To construct and highly express an epitope of hepatitis C virus (HCV) in a foreign epitope presenting vector based on an insect virus, and to study the antigenicity of the epitope.
METHODS: The HCV epitope sequence (amino acid residues 315 to 328: EGHRMAWDMMMNWS) of the E1 region was constructed at different positions of a foreign epitope presenting vector based on an insect virus, flock house virus (FHV) capsid protein encoding gene as a vector, and expressed in E. coli cells. Western blotting and ELISA were used to detect the immunoreactivity of these recombinant proteins.
RESULTS: The gene encoding of the concerned B-cell epitope of HCV E1 envelope protein was expressed on FHV capsid carrier protein at positions I1 (aa 106), I2 (aa 153) and I3 (aa 305), respectively, on the surface of FHV capsid protein. The recombinant proteins in this system could be highly expressed in more than 40% of total cell protein of E. coli BL21. All the expressed recombinant proteins were in inclusion body form, and showed obvious immunoreactivity by Western blotting. Further purified recombinant proteins were detected by indirect ELISA as coating antigen respectively. All recombinant proteins could still show immunoreactivity.
CONCLUSION: The epitope of HCV E1 envelope protein can be highly expressed in FHV carrier system as a chimeric protein with high immunoreactivity. This system has multiple entry sites conferring many possible conformations closer to the native one for a given sequence.
Collapse
Affiliation(s)
- Mei Peng
- Department of Molecular Biology, Institute of Medical Biology, Chinese Academy of Medical Sciences/Peking Union Medical College, 379 Jiaoling Road, Kunming 650118, Yunnang Province, China.
| | | | | |
Collapse
|
4
|
Barathur R, Bookout J, Sreevatsan S, Gordon J, Werner M, Thor G, Worthington M. New disc-based technologies for diagnostic and research applications. Psychiatr Genet 2002; 12:193-206. [PMID: 12454524 DOI: 10.1097/00041444-200212000-00002] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
The role of genotypic analysis in disease diagnostics and drug response assessment is continually expanding. New genomic discoveries combined with new, novel technologies may provide a greater range of testing capabilities in the near future. We describe the application of nanotechnology, in which DNA microarrays have been placed in a microchannel environment that can be read and analyzed in an optical (CD/DVD) disc drive system. The potential exists to combine molecular and immunological applications together into a rapid, low-cost, high-capacity screening platform. The relevance of this technology is discussed in respect to infectious agent detection, pharmacogenomics, neurogenomics and genetic variations associated with neurologic diseases.
Collapse
Affiliation(s)
- Raj Barathur
- Burstein Technologies Inc., Irvine, California 92618, USA.
| | | | | | | | | | | | | |
Collapse
|
5
|
Lee HM, Naor J, Alhindi R, Chinfook T, Krajden M, Mazzulli T, Rootman DS. Detection of hepatitis C virus in the corneas of seropositive donors. Cornea 2001; 20:37-40. [PMID: 11189001 DOI: 10.1097/00003226-200101000-00007] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
PURPOSE There have been no reported cases of hepatitis C virus (HCV) transmission by corneal transplantation. Previous studies have also shown no correlation between HCV seropositivity and the presence of HCV RNA in the corneal tissues. This study aims to investigate such correlation and to provide further evidence to the possible transmissibility of HCV via corneal grafts. METHODS Of the 1,619 potential corneal donors to the Eye Bank of Canada over a 1-year period, 15 tested HCV-positive by the second-generation Abbott HCV enzyme immunoassay (EIA) 2.0 assay. Their sera were further tested with second-generation radio-immunoblot assay (RIBA-II), and their corneas (29 altogether) were processed for identification of HCV RNA using polymerase chain reaction (PCR). RESULTS Of the 29 corneas from seropositive donors, HCV RNA was detected in 7 (24.1%). CONCLUSION This is the first study in the literature that demonstrates a significant correlation between HCV seropositivity and the presence of HCV in the corneas. Routine HCV serologic testing for all potential corneal donors and rejection of corneal tissues based on HCV seropositivity is certainly justifiable.
Collapse
Affiliation(s)
- H M Lee
- Department of Ophthalmology, University of Toronto, The Toronto Hospital, Ontario, Canada
| | | | | | | | | | | | | |
Collapse
|
6
|
Pereboeva LA, Pereboev AV, Wang LF, Morris GE. Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen. J Med Virol 2000. [DOI: 10.1002/(sici)1096-9071(200002)60:2<144::aid-jmv7>3.0.co;2-g] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
7
|
Sreevatsan S, Bookout JB, Ringpis FM, Pottathil MR, Marshall DJ, De Arruda M, Murvine C, Fors L, Pottathil RM, Barathur RR. Algorithmic approach to high-throughput molecular screening for alpha interferon-resistant genotypes in hepatitis C patients. J Clin Microbiol 1998; 36:1895-901. [PMID: 9650932 PMCID: PMC104948 DOI: 10.1128/jcm.36.7.1895-1901.1998] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/1997] [Accepted: 04/02/1998] [Indexed: 02/08/2023] Open
Abstract
This study was designed to analyze the feasibility and validity of using Cleavase Fragment Length Polymorphism (CFLP) analysis as an alternative to DNA sequencing for high-throughput screening of hepatitis C virus (HCV) genotypes in a high-volume molecular pathology laboratory setting. By using a 244-bp amplicon from the 5' untranslated region of the HCV genome, 61 clinical samples received for HCV reverse transcription-PCR (RT-PCR) were genotyped by this method. The genotype frequencies assigned by the CFLP method were 44.3% for type 1a, 26.2% for 1b, 13.1% for type 2b, and 5% type 3a. The results obtained by nucleotide sequence analysis provided 100% concordance with those obtained by CFLP analysis at the major genotype level, with resolvable differences as to subtype designations for five samples. CFLP analysis-derived HCV genotype frequencies also concurred with the national estimates (N. N. Zein et al., Ann. Intern. Med. 125:634-639, 1996). Reanalysis of 42 of these samples in parallel in a different research laboratory reproduced the CFLP fingerprints for 100% of the samples. Similarly, the major subtype designations for 19 samples subjected to different incubation temperature-time conditions were also 100% reproducible. Comparative cost analysis for genotyping of HCV by line probe assay, CFLP analysis, and automated DNA sequencing indicated that the average cost per amplicon was lowest for CFLP analysis, at $20 (direct costs). On the basis of these findings we propose that CFLP analysis is a robust, sensitive, specific, and an economical method for large-scale screening of HCV-infected patients for alpha interferon-resistant HCV genotypes. The paper describes an algorithm that uses as a reflex test the RT-PCR-based qualitative screening of samples for HCV detection and also addresses genotypes that are ambiguous.
Collapse
Affiliation(s)
- S Sreevatsan
- Center for Innovative Technologies, ClinCyte, San Diego, California 92121, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Woźny W, Piasek A, Elbaum D. Simultaneous detection of hepatitis C virus and human immunodeficiency virus RNA in serum using amplicor PCR tests. Viral Immunol 1997; 10:73-82. [PMID: 9210281 DOI: 10.1089/vim.1997.10.73] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
Several tests are currently available to assist in the diagnosis of the hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Tests that actually detect or quantify these viruses are based on the polymerase chain reaction (PCR) technique. However, the application of PCR is limited by the cost, labor, time-consumption, and potential for contamination. In this article we describe some procedures developed to reduce these limitations. We have developed and validated simultaneous detection methods for HIV RNA and HCV RNA in single serum samples using Amplicor PCR tests. The sensitivity and specificity of this method are comparable with the results obtained with commercial reverse transcription polymerase chain reaction (RT-PCR) techniques for HIV and HCV RNA detection. In addition we have modified the HIV Amplicor test for the RT-PCR procedure and the Chomczynski's method of RNA isolation. We hope that our method can find same applications in HIV and HCV coinfection research, blood screening, and medical diagnosis.
Collapse
Affiliation(s)
- W Woźny
- Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland
| | | | | |
Collapse
|
9
|
Jungkind D, Direnzo S, Beavis KG, Silverman NS. Evaluation of automated COBAS AMPLICOR PCR system for detection of several infectious agents and its impact on laboratory management. J Clin Microbiol 1996; 34:2778-83. [PMID: 8897182 PMCID: PMC229403 DOI: 10.1128/jcm.34.11.2778-2783.1996] [Citation(s) in RCA: 76] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
We evaluated the COBAS AMPLICOR (CA) PCR system (Roche Diagnostic Systems) designed for automated PCR amplification and detection of nucleic acids from infectious agents in clinical samples. The Roche AMPLICOR microwell plate (MWP) PCR was the reference method. CA amplifies target nucleic acid, captures the biotinylated amplification products by using magnetic particles coated with specific oligonucleotide probes, and detects the bound products colorimetrically. For Mycobacterium tuberculosis, the correlation of the results of CA tests with those of MWP tests was 100% with 230 samples, including 20 culture-positive samples. For hepatitis C virus, the correlation was 100% with 214 samples, including 60 positive samples. MultiPlex CA analysis of 199 cervical specimens for Chlamydia trachomatis, Neisseria gonorrhoeae, and the internal control gave 100% concordance. These samples included 19 C. trachomatis and 3 N. gonorrhoeae culture-positive samples. Overall, the agreement between PCR methods for all 842 comparisons was 100%. Compared with culture, the sensitivities of the assays for C. trachomatis and M tuberculosis were > or = 95%. After spiking alternating amplification tubes in the CA system with 10(14) copies of the Chlamydia amplicon per ml, we were unable to demonstrate any carryover cross-contamination of negative samples. Using the criteria of the College of American Pathologists workload recording method, we found that the total hands-on time to produce CA PCR results was 4.4, 7.9, and 3.3 min for M. tuberculosis, hepatis C virus, and the MultiPlexed assay for chlamydia plus gonorrhea and an internal control, respectively. The CA system brings true PCR automation to laboratories. In addition to the accuracy of automated results, the CA system provides labor savings, provides containment of the amplification and detection components of PCR, and supports both MultiPlex amplification and sequential algorithm (ReFlex) detection of analytes.
Collapse
Affiliation(s)
- D Jungkind
- Department of Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
| | | | | | | |
Collapse
|